Compare CLIR & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLIR | NBY |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.3M | 31.6M |
| IPO Year | 2011 | 2007 |
| Metric | CLIR | NBY |
|---|---|---|
| Price | $4.36 | $1.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 16.2K | ★ 608.2K |
| Earning Date | 04-09-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $530,000.00 | $370,000.00 |
| Revenue This Year | $34.29 | N/A |
| Revenue Next Year | $67.31 | N/A |
| P/E Ratio | ★ N/A | $2.57 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.39 | $0.43 |
| 52 Week High | $7.56 | $19.95 |
| Indicator | CLIR | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 47.91 | 57.82 |
| Support Level | $4.18 | $1.01 |
| Resistance Level | $4.75 | $2.52 |
| Average True Range (ATR) | 0.41 | 0.26 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 30.43 | 96.45 |
ClearSign Technologies Corp is engaged in designing and develop technologies for the purpose of decarbonization and improving key performance characteristics of industrial and commercial combustion systems, including emission and operational performance, energy efficiency and overall cost-effectiveness. Its ClearSign Core technology has been proved to be in full scale industrial test furnaces and boilers and first customer installations are currently operating in normal commercial applications The company offers products that include process burners, boiler burners, flares, and ClearSign Eye. The company operates in one segment: Combustion segment. The products of the company include: Process Burners, Midstream and Power, Flares, Boiler Burners, and Sensing Technology.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.